Loading...
Market
Will Ozempic sales in China exceed $1 billion by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Quarterly and annual financial reports from Novo Nordisk (manufacturer of Ozempic)
Story
China Adopts Ozempic in Weight Loss Guidelines, British Heart Foundation Optimistic
Sep 3, 2024, 06:04 AM
New guidelines from a leading medical advisory body in China are incorporating 'miracle cure' medications such as Ozempic into weight loss treatments, potentially changing the lives of millions and boosting sales for drugmakers. Bryan Williams from the British Heart Foundation expressed optimism about Ozempic's potential to help with extreme weight loss and other conditions. Ozempic, originally developed to treat diabetes, has shown promise in aiding weight loss and reducing risks of cardiovascular issues. Recent studies indicate that semaglutide, the active ingredient in Ozempic, is effective in reducing the progression from prediabetes to type 2 diabetes. Despite the enthusiasm, experts urge caution, noting the need for long-term studies to fully understand the drug's effects. Additionally, new research has found no increased risk of mental health issues among users of semaglutide for weight loss.
View original story
Similar markets
Yes • 50%
No • 50%
Increased Sales • 25%
Decreased Sales • 25%
No Significant Change • 25%
Product Recall • 25%
< $500 million • 33%
$500 million - $1 billion • 33%
> $1 billion • 34%
Yes • 50%
No • 50%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change • 25%
Price competitiveness • 25%
Efficacy and safety profile • 25%
Marketing and distribution • 25%
Regulatory support • 25%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change • 25%
No action taken • 25%
Safety label update • 25%
Product recall • 25%
Other regulatory actions • 25%